Literature DB >> 17569850

Immunology. The shape of things to come.

Katherine A Fitzgerald1, Douglas T Golenbock.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17569850     DOI： 10.1126/science.1144483

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  7 in total

Review 1.  Hijacking the T-cell communication network by the human T-cell leukemia/lymphoma virus type 1 (HTLV-1) p12 and p8 proteins.

Authors:  Nancy Van Prooyen; Vibeke Andresen; Heather Gold; Izabela Bialuk; Cynthia Pise-Masison; Genoveffa Franchini
Journal:  Mol Aspects Med       Date:  2010-07-29

2.  Escherichia coli mutants that synthesize dephosphorylated lipid A molecules.

Authors:  Brian O Ingram; Ali Masoudi; Christian R H Raetz
Journal:  Biochemistry       Date:  2010-09-28       Impact factor: 3.162

Review 3.  Putting endotoxin to work for us: monophosphoryl lipid A as a safe and effective vaccine adjuvant.

Authors:  C R Casella; T C Mitchell
Journal:  Cell Mol Life Sci       Date:  2008-10       Impact factor: 9.261

4.  CpG-ODN and MPLA prevent mortality in a murine model of post-hemorrhage-Staphyloccocus aureus pneumonia.

Authors:  Antoine Roquilly; Laetitia Gautreau; Jean Pierre Segain; Pierre de Coppet; Véronique Sebille; Cédric Jacqueline; Jocelyne Caillon; Gilles Potel; Corinne Lejus; Régis Josien; Karim Asehnoune
Journal:  PLoS One       Date:  2010-10-07       Impact factor: 3.240

Review 5.  Personalized vaccines: the emerging field of vaccinomics.

Authors:  Gregory A Poland; Inna G Ovsyannikova; Robert M Jacobson
Journal:  Expert Opin Biol Ther       Date:  2008-11       Impact factor: 4.388

Review 6.  Vaccinomics and personalized vaccinology: is science leading us toward a new path of directed vaccine development and discovery?

Authors:  Gregory A Poland; Richard B Kennedy; Inna G Ovsyannikova
Journal:  PLoS Pathog       Date:  2011-12-29       Impact factor: 6.823

7.  Efficacy and safety of a liposome-based vaccine against protein Tau, assessed in tau.P301L mice that model tauopathy.

Authors:  Clara Theunis; Natalia Crespo-Biel; Valérie Gafner; Maria Pihlgren; María Pilar López-Deber; Pedro Reis; David T Hickman; Oskar Adolfsson; Nathalie Chuard; Dorin Mlaki Ndao; Peter Borghgraef; Herman Devijver; Fred Van Leuven; Andrea Pfeifer; Andreas Muhs
Journal:  PLoS One       Date:  2013-08-19       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.